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Abstract
This paper investigates the anticipated trademark problems may result from tobacco control 
regulations, particularly the warning label requirements implemented in WTO members and the 
stricter regulation of plain packaging promulgated in Australia (“tobacco measures”). Following 
the adoption of the Framework Convention on Tobacco Control (“FCTC”) in May 2003 (enforce 
by February 2005), member countries tend to seek for possibilities to implement and use stricter 
approach to achieve their public health policy. As the core concept and main goal of WTO is trade 
liberalization, regardless of types of goods traded among members, whereas the stricter restriction on 
trademark use means the prohibition of exploiting intellectual property rights of trademark owners, 
TRIPS is thus unavoidably related and has been brought by tobacco companies to be against the 
regulations, claiming that this poses unjustifiable trade barriers to business and denying its legitimacy 
in corresponding to the WTO obligations. To what extent the FCTC instructs or entitles members to 
pose barriers on trade in tobacco basing on public health purpose? Is there any correlation between 
the FCTC, a framework adopted under World Health Organization (“WHO”), and the covered 
agreements under WTO such as TRIPS? 
Keywords: warning label, plain-packaging, TRIPS, tobacco control regulation, 
Framework Convention on Tobacco Control, FCTC, public health policy
I. INTRODUCTION
Cigarette smoking is the single biggest avoidable cause of death and 
disability in developed countries2. It has been, from time to time, rap-
idly increasing before the Second World War in the developing coun-
tries3 and becomes one of the biggest threats to current and future world 
1 * Lecturer in Law, School of Law, Assumption University of Thailand; LLB, iMBA-Law 
(National Taiwan University of Science and Technology, Republic of China), PhD candi-
date (College of Law, National Taiwan University, Republic of China); Registered Lawyer 
of Thailand; Notarial Services Attorney of Thailand. The author would like to thank Prof. 
Lo Chang-fa for his advice during my research on the topic and also my former colleague, 
Ms. Pattaravadee Kongcharoenniwat for her comments. The author can be reached at nat-
tapong.suwan-in@au.edu and law.ghchen@gmail.com. The usual disclaimer applies.
2  See general Richard Edwards, the Problem of Tobacco Smoking, Clinical Review (2004), 
available at http://www.bmj.com/content/328/7433/217.full (last visited Jun. 17, 2012). 
3  P. Vateesatokit, B. Hughes and B. Ritthphakdee, Thailand: Winning Battles, but the War’s 
Far from Over (2000), at 1, available at http://bmj-tobacco.highwire.org/content/9/2/122.
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health as it does not affect only to people but also provide social and 
unavoidable economic consequences. It is estimated that tobacco use 
causes death for more than five million people a year and the number 
could raise to more than eight million by 2030 unless measures are 
taken to control the tobacco epidemic4 .  
To cope with the situation, various measures have been adopted to 
control tobacco consumption5. This includes the early policy of warn-
ing label requirement (“health warning label”) that has been being used 
in many countries as well as the recent development of the stricter rule 
of tobacco control such as plain packaging (“plain package”) in Austra-
lia adopted in 20116. In Thailand, one of the early countries adopted the 
control measures, because of a high consumption of tobacco in the coun-
try back in 1980s7, with internal force of public8, government passed the 
Tobacco Products Control Act B.E. 2535 and the Non-Smokers’ Health 
Protection Act B.E. 2535 which cover important provisions on i) total 
ban on tobacco advertising, promotion and sponsorship, ii) prohibition 
of youth access to tobacco (under 18), iii) disclosure of constituents and 
emission of product to the Ministry of Public Health, iv) warning label 
requirement with 9 pictorial health warnings, and v) prohibition of the 
misleading descriptors such as “light” or “mild”, and so on.9 . These fol-
lowed after the first ban on tobacco advertising of Thai government by 
including tobacco in the dangerous products category under the Con-
sumer Protection Act which brought WTO dispute against Thailand on 
GATT violation10 . 
While in US, the battle between big tobacco companies and US 
government also brought some social awareness, evidenced in the law-
full (last visited Jun. 17, 2012).
4  Valentina S. Vadi, Global Health Governance at a Crossroads: Trademark Protection v. 
Tobacco Control in International Investment Law, 48 Stan. J. Int’l L. 93 (2012), at 95-96.
5  Such as plain packaging, prohibition on promotion and advertisement, excise tax and etc. 
6  Tania Voon, Acquisition of Intellectual Property Rights: Australia’s Plain Tobacco Pack-
aging Dispute, E.I.P.R. 2013, 35(2), 113-118 (2013), at 113-114.
7  See Vateesatokit, Hughes and Ritthphakdee, supra note 2, at 2.
8  Id. 
9  Thailand Tobacco Products Control Act B.E. 2535 (1992), sec. 4, sec. 8-9, and sec. 11-
13 . 
10  Panel Report, Thailand-Restriction on Importation of Internal Taxes on Cigarettes, 
BISD/37/S/200 (Nov. 7, 1990).
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suits against the Food and Drug Administration (“FDA”) of the five 
tobacco companies and R.J. Reynolds before the federal court in Ken-
tucky. This happened soon after the President Obama signed the Family 
Smoking Prevention and Tobacco Control Act (“FSPTCA”) in 2009, 
which gives FDA authority to regulate tobacco products and amends 
the Federal Cigarette Label Advertising Act to require cigarette makers 
to place larger warning labels on their package. The claims based on 
the ground of constitution and freedom of speech violation as well as 
trademark (including trade dress) infringement11. In European Union 
(“EU”), after the European Parliament and the Council of the EU have 
adopted the Directive in 200112, label litigations were also raised to op-
pose by tobacco companies, claiming an infringement of Article295 EC 
and member states’ systems of property ownership and a violation of 
trademark provisions in TRIPS. Among various issues under consider-
ation of the European Court of Justice (“ECJ”), a number of provisions 
in TRIPS (i.e. Article 8 and Article 17) were ignored by court to strike 
down to rule a precedent13 and left important issues undecided on its le-
gitimacy. Along with stricter approach of the plain package being used 
in Australia and the problem on uncertainty of legal compatibility of the 
tobacco regulations with TRIPS, many contentious issues are yet un-
solved but can likely be settled by the use of an interpretative tool avail-
able in the Vienna Convention on the Law of Treaty or VCLT14 . At least 
in the contexts of the warning label requirement and the plain packag-
ing regulation, Articles 31 and 32 are undeniably relevant according to 
TRIPS Article 64.1 that can be used for purpose of interpretation of the 
arguments in Articles 8, 15, 16, 17 and 20. The research can be expected 
to produce a reliable-legal-base answer and provide public analyzing 
steps to base on. This is according to the customary rule of interpreta-
tion that TRIPS should, at the end, comply. 
11  See generally Benjamin A. Hackman, On the Mark? Big Tobacco Asserts Property 
Rights on Cigarette Packaging, 29 Penn St. Int’l L. Rev. 809 (2011).
12  Id., at 811.
13  Id., at 817.
14  See generally Vienna Convention on the Law of Treaties, 1155 U.N.T.S 331, 8 I.L.M. 
679 (1969) [hereinafter VCLT] art. 31 and art. 32.
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II. INTRODUCTION TO FUNDAMENTAL RULES OF TRIPS 
AND TRADEMARK
TRIPS or the Agreement on Trade-Related Aspects of Intellectual 
Property Rights, constituting as Annex 1C of the Agreement Establish-
ing the World Trade Organization (“WTO Agreement”)15, is the most 
comprehensive international agreement on intellectual property pro-
tection16. With pressure from the United States Trade Representative 
(“USTR”) through the use of the Special 30117 , TRIPS was concluded 
and put into force in 1995, setting down a minimum standard of pro-
tection, in many forms of intellectual property (“IP”). With respect to 
trademark, TRIPS recognizes trademark and provides protections de-
tailed in Section 2 of Part II, Standards Concerning the Availability, 
Scope and Use of IPRs, which covers seven provisions. Looking back 
into TRIPS’ history, the regulation on trademark was not a major nego-
tiation issue as controversial as patents. The major dissent between the 
two sides of developed and developing countries in the field of trade-
mark, in retrospect, was the extent to i) which rules complementing the 
Paris Convention should be harmonized in a future agreement within 
the GATT and ii) whether countries could continue establishing them at 
the national level. As the consequence, the first compilation proposed 
by the Chair was the substantive and procedural shortcomings of trade-
mark protection in GATT, which revealed no major problems in Paris 
Convention, and TRIPS was so drafted in the way to compile and pro-
vide some clarifications18 . 
Though TRIPS seems to complete what Paris Convention lacked, as 
the parties initially put forward of their emphasis on the international 
harmonization of IP standard and enforcement especially on patent, the 
provisions of trademark, in comparison to patents, are likely regulated 
imbalanced. That being said, though TRIPS acknowledges trademark as 
15  WTO Agreement, Marrakesh Agreement Establishing the World Trade Organization, 
Apr. 15, 1994, The Legal Texts: The Results Of The Uruguay Round Of Multilateral Trade 
Negotiations 4 (1999), 1867 U.N.T.S. 154, 33 I.L.M. 1144 (1994), List of Annexes, An-
nex 1C: Agreement on Trade-Related Aspects of Intellectual Property Rights [hereinafter 
WTO Agreement].
16  Terence P. Stewart, The GATT Uruguay Round: A Negotiating History, 478-79 (1993).
17  Id.
18  Id., at 207-208.
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a private right similarly to patent19 described in the Preamble, it seem-
ingly fails to recognize “the enjoyment of right without discrimination”. 
By comparing with patent provision in Article 27, whether this failure 
is good or not, the terms carefully chosen should literally connote a 
limited protection of trademark rights given to owners such in a manner 
of being restricted to the Articles 15, 16, 17 and 20. This primary under-
standing is important to analysis on legitimacy of the tobacco measures 
in the following chapter such as the warning label and plain package20 . 
As trademark is long recognized to function as to i) promote market and 
sell products (advertising function), ii) refer to a particular enterprise 
(differentiation function), iii) refer to a particular quality of the product 
(guarantee function), and iv) indicate origin or source of one’s prod-
uct from others’ (indication of origin function)21, impacts on trademark 
functions and practical trademark system shall also be important that 
deserve to mention and include in the study. This is in order to manifest 
the consequences of tobacco measures in practice, a view of holistic-
approach perspective that current research rarely touched upon.
III. DISPUTES ON TRIPS AGREEMENT AND TREATY INTER-
PRETATIVE TOOLS
DSB and Dispute Settlement Understanding (“DSU”) are not relat-
ed to TRIPS merely because Article 64.1 so indicates but also the nature 
of the dispute itself that lies upon the enforcement of the dispute settle-
ment process promulgated in the DSU. Under umbrella of WTO, ac-
cording to Article 3.2, the DSU provides that interpretation of all WTO 
agreements, including TRIPS, shall be “in accordance with custom-
19  Agreement on Trade Related Aspects of Intellectual Property Rights, Apr. 15, 1994, 
Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, The Legal 
Texts: The Results Of The Uruguay Round Of Multilateral Trade Negotiations 320 (1999), 
1869 U.N.T.S. 299, 33 I.L.M. 1197 (1994) [hereinafter TRIPS Agreement] Preamble par. 4 
provides: “Recognizing that intellectual property rights are private right…”.
20  See generally Trevor Stevens, Tobacco Plain Packaging Reforms: What They Mean to 
Australian Trademark Law and our International Obligation (2011), available at http://
www.davies.com.au/pub/detail/501/tobacco-plain-packaging-reforms-what-they-mean-
for-australian-trade-mark-law-and-our-international-obligations (last visited Jun. 18, 
2012). 
21  Wat Tingsamij, Explanation of Trademark Law, 3 (2002).
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ary rules of interpretation of public international law”22, known in the 
name of the Vienna Convention. As evidenced in a number of reports of 
Panel and Appellate Body (“AB”), discussion on TRIPS disputes usu-
ally begin with explanation of its correlation with the VCLT and end 
up with application and then adjudication. In India-Patent Protection 
for Pharmaceutical and Agricultural Chemical Products, the AB has 
stated that “ . . .the duty of a treaty interpreter is to examine the words 
of the treaty to determine the intentions of the parties. This should be 
done in accordance with the principles of treaty interpretation set out 
in Article 31 of the Vienna Convention. . .”.23 Thus, it is very rational 
to start our analysis of legitimacy of the health warning label and plain 
packaging regulations by reviewing the tools of interpretation, starting 
with Article 31, the General Rule of Interpretation, of the provisions in 
the VCLT24 . 
A. VCLT
Article 31: General Rule of Interpretation reads:
1.  A treaty shall be interpreted in good faith in accordance with the 
ordinary meaning to be given to the terms of the treaty in their 
context and in the light of its object and purpose.
22  Understanding on Rules and Procedures Governing the Settlement of Disputes, Mar-
rakesh Agreement Establishing the World Trade Organization, Annex 2, The Legal Texts: 
The Results Of The Uruguay Round Of Multilateral Trade Negotiations 354 (1999), 1869 
U.N.T.S. 401, 33 I.L.M. 1226 (1994) [hereinafter DSU] art. 3.2 provides: “The dispute 
settlement system of the WTO is a central element in providing security and predictability 
to the multilateral trading system. The Members recognize that it serves to preserve the 
rights and obligations of Members under the covered agreements, and to clarify the exist-
ing provisions of those agreements in accordance with customary rules of interpretation 
of public international law. Recommendations and rulings of the DSB cannot add to or 
diminish the rights and obligations provided in the covered agreements”.
23  Appellate Body Report, India – Patent Protection for Pharmaceutical and Agricul-
tural Chemical Products, 45, WT/DS50/AB/R (Dec. 19, 1997) [hereinafter India-Patent 
for Pharmaceuticals Appellate Body Report]; Panel Report, India – Patent Protection 
for Pharmaceutical and Agricultural Chemical Products, WT/DS50/R (Sept. 5, 1997), as 
modified by Appellate Body Report.
24  Nattapong Suwan-in, Compulsory License, A Long Debate on TRIPS Agreement Inter-
pretation: Discovering the Truth of Thailand’s Imposition on Pharmaceutical Patents, 7 
Asian J. WTO & Int’l Health L. & Pol’y 225 (2012), at 231-232.
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2.  The context for the purpose of the interpretation of a treaty shall 
comprise, in addition to the text, including its preamble and annexes:
a)  Any agreement relating to the treaty which was made between 
all the parties in connection with the conclusion of the treaty;
b)  Any instrument which was made by one or more parties in con-
nection with the conclusion of the treaty and accepted by the 
other parties as an instrument related to the treaty.
3.  There shall be taken into account, together with the context:
a)  Any subsequent agreement between the parties regarding the in-
terpretation of the treaty or the application of its provisions;
b) Any subsequent practice in the application of the treaty which 
establishes the agreement of the parties regarding its interpreta-
tion;
c) Any relevant rules of international law applicable in the rela-
tions between the parties.
Article 31 begins its core concept of interpretation with a plain 
meaning against a broader context of holistic approach. Though there is 
no term holistic or rational in the provision, its key captures the corner-
stone that TRIPS must be interpreted in good faith in accordance with 
the ordinary meaning to be given to the terms in their context and in the 
light of its object and purpose. The wording suggests a logic of human 
nature and cogent belief that interpretation must be first started some-
where with the ordinary terms and its meanings before extending its un-
derstanding to surrounding context as well as object and also purpose25 . 
As Prof. Susy Frankel described Article 31 as a “logical progression” 
rather than a “hierarchy of legal norms”26 and the Appellate Body in 
United States-Standards for Reformulated and Conventional Gasoline 
has also confirmed that the need to apply other rules of international law 
is unnecessary if Article 31.1 already provides the answer27, in consid-
eration of the case of tobacco measures, our analysis shall then accord-
ingly be scoped and focused on i) the treaty terms provided in TRIPS, 
ii) its object and purpose provided in Article 8, iii) TRIPS’ preamble, 
25  Id., at 232-233.
26 Susy Frankel, WTO Application of “the Customary Rules of Interpretation of Public 
International Law” to Intellectual Property, 46(2) Va. J. Int’l L. 365, 386 (2006).
27  Appellate Body Report, United States – Standards for Reformulated and Conventional 
Gasoline, WT/DS2/AB/R (Apr. 29, 1996).
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and iv) any subsequent agreement or practice or any relevant rules by 
means of VCLT Article 31.3, in order to conclude if the measures are in 
violation of provisions in TRIPS. To facilitate an interpretation, FCTC 
and the Doha Declaration on Public Health (“Doha Declaration”) are 
usually brought by implementing states to support their legitimacy and 
compatibility with international obligations. To what extent FCTC can 
be used to support government’s argument and to what extent FCTC 
can entitle Member states to pose barrier on trade in tobacco, resulted 
from the warning label and/or plain packaging requirement, as claimed 
by Australia?28 In response to these, our analytical study in the follow-
ing session will hence demonstrate the correlation of the FCTC, the 
Doha Declaration, and TRIPS by means of Article 31 of the VCLT. As 
the Doha Declaration was previously analyzed in the author’s article29 
and it is nowadays confirmed by the AB’s decision in US-Clove Cig-
arettes that the Declaration can constitute as a subsequent agreement 
subject to VCLT Article 31.3(a)30, the one problem left for determina-
tion is then the legal status of the FCTC. This is in order to solve the 
TRIPS-violation-dispute questions. 
B. FRAMEWORK CONVENTION ON TOBACCO CONTROL: ITS 
ROLE AND THE LEGAL STATUS
1. Introduction to the Framework Convention on Tobacco Control — 
The WHO Framework Convention on Tobacco Control or FCTC 
is the first treaty adopted in World Health Organization by virtue 
of Article 19 of the Constitution. Within the competence of the 
organization, Health Assembly of WHO has authority to adopt 
conventions or agreements with respect to any matter related31 . 
28  Australia Tobacco Plain Packaging Act 2011, No.148, 2011, Sec. 3 (1)(b) provides: “to 
give effect to certain obligations that Australia has as a party to the Convention on Tobacco 
Control”; See also Tania Voon, Flexibilities in WTO Law to Support Tobacco Control 
Regulation, 39 Am. J.L. & Med. 199 (2013), at 204-205.
29  See generally Suwan-in, supra note 23 .
30  See Benn McGrady, Revisiting TRIPS and Trademark: the Case of Tobacco (2012), at 
2, available at http://ssrn.com/abstract=2144269 (last visited Jul. 29, 2013).
31  World Health Organization Constitution, 14 U.N.T.S 185 (1948) [hereinafter WHO 
Constitution] art. 19 provides: “The Health Assembly shall have authority to adopt con-
ventions or agreements with respect to any matter within the competence of the Organiza-
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To the first time that the Health Assembly has ever adopted, WHO 
activated its constitution to develop the treaty to protect present and 
future generations from health, social and economic consequences 
of tobacco use32. Especially at this time when the global nature of the 
tobacco epidemic required a global health governance mechanism 
to effectively address the problem, the move represented a major 
breakthrough in international public health law as WHO has never 
before adopted conventions, despite of the instruments, for instance, 
recommendations and regulations33. The convention reflects 
scientific consensus on the lethal effects of tobacco smoke and 
advances global cooperation for tobacco control34, so adopted on 
May 21, 2003 in the 56th World Health Assembly and came into force 
on February 27, 200535. It contains thirty-eight provisions in total, 
regulates from the rules that govern production, sale, distribution, 
advertisement, and taxation of tobacco to protection of environment 
and settlement of disputes, just to name a few. Similarly to TRIPS, 
FCTC provides minimum standard of requirements suggested to its 
member. Because the FCTC, by law, binds only the state parties 
that have ratified it (currently signed by 168 countries and of 177 
ratifying countries36), in case where there is conflict with other treaty 
regimes such as TRIPS, one may question about its legal status and 
their correlation. This is especially when the FCTC suggests and 
uses a non-obligatory language and even a very open-ended term.  
tion. A two-thirds vote of the Health Assembly shall be required for the adoption of such 
conventions or agreements, which shall come into force for each Member when accepted 
by it in accordance with its constitutional processes”.
32  World Health Organization Constitution, Framework Convention on Tobacco Control 
(2005) [hereinafter FCTC] art. 3 provides: “The objective of this Convention and its pro-
tocols is to protect present and future generations from the devastating health, social, envi-
ronmental and economic consequences of tobacco consumption and exposure to tobacco 
smoke by providing a framework for tobacco control measures to be implemented by the 
Parties at the national, regional and international levels in order to reduce continually and 
substantially the prevalence of tobacco use and exposure to tobacco smoke”.
33  See Vadi, supra note 3, at 100-101.
34  Id., at 101-102.
35  Wikipedia, the Free Encyclopedia, World Health Organization Framework Convention 
on Tobacco Control, http://en.wikipedia.org/wiki/World_Health_Organization_Frame-
work_Convention_on_Tobacco_Control (last visited Aug. 26, 2013).
36  Id.
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2. FCTC and its Legal Status subject to the Vienna Convention. 
— FCTC, by relying on Article 19 of the Constitution37, is an 
international convention or agreement legitimately resolved via 
voting at the ratio of two thirds in majority by the assembly and 
also in pursuit of the constitutional procedure38. To likely constitute 
as a subsequent agreement according to points of views of some 
scholars, claiming that FCTC can be a ground to strengthen and 
support developing countries from departure of their burden of 
disease from tobacco when this sort of tobacco control infrastructure 
was absent, to our remark that the FCTC is a framework convention 
under the WHO, while TRIPS is of or belongs to the WTO, to be 
interpreted in conjunction with Article 31 of the VCLT, we found 
difficulty to agree with the notion with two main reasons in support 
of our argument.
First, FCTC and TRIPS are separated agreements, came to alive 
for each individual purpose and launched in a different period of time. 
While the FCTC, under WHO, has objectives to protect human health 
and social consequences from tobacco use, TRIPS, on the other hand is 
under WTO, mainly aimed to overcome the problem of discrimination 
and generate free trade. As the previous decision made by AB in the 
ACP-EC Partnership Agreement39 has previously ruled that “the mate-
rial issues to consider a subsequent agreement by the meaning of Ar-
ticle 31.3(a) of the VLCT shall be (i) adopted by the same parties as of 
the covered treaty,40(ii) characterized as an agreement bearing specifi-
cally upon the interpretation of a treaty which is, in the WTO context, 
adopted pursuant to Article IX:2 of the WTO Agreement,41 and (iii) in 
37  See supra note 30 .
38  Id. 
39  See generally Ministerial Conference, European Communities – The ACP-EC Partner-
ship Agreement, WT/MIN(01)/15 (Nov. 14, 2001), available at http://www.wto.org/eng-
lish/thewto_e/minist_e/min01_e/mindecl_acp_ec_agre_e.pdf. (last visited Mar. 20, 2012).
40  World Trade Organization [WTO], 18 Dispute Settlement Reports 2008 7281 (June 28, 
2010). “We agree with the Panel that the Doha Article 1 Waiver was adopted by the same 
parties that approved the European Communities’ Schedule . . . .”
41  Id., at 7281-82 (the International Law Commission (ILC) describes a subsequent agree-
ment within the meaning of Articles 31(3)(a) of the Vienna Convention as a further au-
thentic element of interpretation to be taken into account together with the context”. In our 
view, by referring to “authentic interpretation”, the ILC reads Article 31(3)(a) as referring 
to agreements bearing specifically upon the interpretation of a treaty. In the WTO context, 
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force as to interpret the covered treaty, not to connote the creation of 
new obligation or modification of the covered treaty”,42 it is difficult to 
say that FCTC is a subsequent treaty adopted pursuant to Article IX:2 
of the WTO Agreement and in force to interpret TRIPS, the covered 
agreement and treaty in dispute. This is though a scholar such as Prof. 
Benn McGrady likely sees the provisions of FCTC being relevant in 
interpretation of WTO law (so as its guideline), regardless of the fact 
that it was made under WHO43. Without support from the Panel’s and 
AB’s decisions in the recent case of US-Clove Cigarettes that conclud-
ed nothing explicitly regarding the legal status of the FCTC but literally 
and merely, an acknowledgement and recognition of importance of to-
bacco control to Member countries44, therefore, it is thorny to conclude 
that the FCTC can contribute to interpret TRIPS as a subsequent agree-
ment though some proponents and implementing countries may so far 
attempt to claim so45 .
Second, the authority of the Health Assembly, according to Article 
19 of the WHO constitution, is limited to only the adoption of conven-
multilateral interpretations adopted pursuant to Article IX:2 of the WTO Agreement are 
most akin to subsequent agreements within the meaning of Article 31(3)(a) of the Vienna 
Convention . . . .” The Doha Declaration is also adopted pursuant to Article IX:2 of the 
WTO Agreement because it was proposed initially through the TRIPS Council which in 
turn made recommendations to the General Council and the General Council then reported 
to the Ministerial Conference at Doha, which oversaw the functioning of the TRIPS (An-
nex 1C), and approved by consensus from all Members. Article IX:2 reads “The Min-
isterial Conference and the General Council shall have the exclusive authority to adopt 
interpretations of this Agreement and of the Multilateral Trade Agreements. In the case of 
an interpretation of a Multilateral Trade Agreement in Annex 1, they shall exercise their 
authority on the basis of a recommendation by the Council overseeing the functioning of 
that Agreement. The decision to adopt an interpretation shall be taken by a three-fourths 
majority of the Members. ).
42  Id., at 7282 .
43  Benn McGrady, Trade and Public Health: The WTO, Tobacco, Alcohol, and Diet, 36-37 
(2011) “The basic obligations set out in a number of provisions have been supplemented 
by guidelines that are an expression of best practice… assuming this to be the case, these 
guidelines arguably fill out the content of basic FCTC obligations and would be relevant 
in interpretation of WTO law in much the same way as the provisions of the FCTC itself”.
44  See Voon, supra note 27; See also McGrady, supra note 29, at 6; See also Tania Voon, 
Note on WTO Appellate Body Report in US-Measures Affecting the Production and 
Sale of Clove Cigarettes (2012), at 8, available at http://papers.ssrn.com/sol3/papers.
cfm?abstract_id=2143804 (last visited Jul. 31, 2013).
45  See Voon, supra note 43, at 204-205.
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tions or agreements with respect to matters within the competence of 
the Organization. As the context imparts, “within the competence of 
the Organization” and its ordinary meaning explain a limited scope of 
authority that the assembly is allowed to restrictly be on a health re-
lated issue that shall become the gist of the agreement. The terms make 
us understand that it is probably going too far to conclude that this 
includes an interpretative function to explain trade related matter and 
provision such specified in TRIPS. 
Found in the same provision, apart from the subsection 3(a), the 
VCLT further regulates other interpretative tools that are yet applicable 
to the FCTC for purpose of interpretation. According to this issue, if 
both parties in dispute adopt the FCTC provisions into their practice, it 
is possibly that the FCTC can work as a subsequent practice (VCLT Ar-
ticle 31.3(b), or at least as a relevant rule of international law, pursuant 
to the VCLT Article 31.3(c), defined by the International Law Commis-
sion46.  However, viewing FCTC from the Article 31.3(c) perspective, 
Prof. Tania Voon from Melbourne Law School likely sees some diffi-
culties of applying the provision. They are i) the concept or definition 
of the relevant rules of international law47, and ii) the interpretation of 
the term “between the parties”, that both subsections (a) and (c) share 
in common. Despite of the fact that a relevant rule of international law 
can work across international organizations, such as the FCTC under 
WHO to the interpretation of TRIPS under WTO48, to precisely prove 
46  “Relevant” means that the rules are on the same subject matter or that in any way affect 
the specified interpretation. The term “international law” without adjective should denote 
public international law, rather than private international law which is specified and under 
the principle of conflict of laws. Further, the phrase “applicable in the relations between 
the parties” supports that even treaty obligations are covered by Article 31 (3) (c). That 
was a particularly important matter where one treaty had to be interpreted in the light of 
other treaties binding on the parties. Moreover, this phrase should refer to parties to the 
treaty that is being interpreted.
47  Sebastian Mantilla Blanco, the Interpretation of the WTO Agreement (2010), 
at 16, available at  http://www.javeriana.edu.co/juridicas/pub_rev/univ_est/
documents/4Interpretacion.pdf (last visited Jul. 29, 2013).
48  See Voon, supra note 27, at 205-206. “The uncertainty surrounding the scope of VCLT 
Article 31(3)(c) need not pose a significant barrier to panels or the Appellate Body refer-
ring to the WHO FCTC in the course of resolving tobacco-related disputes, because Ar-
ticle 31(3)(c) does not provide the only means of referring to non-WTO law in the course 
of interpretation…”; See also Panel Report EC-Measures Affecting the Approval and Mar-
keting of Biotech Products, 7.68, WT/DS291/R, WT/DS292/R, WT/DS293/R (Sept. 29, 
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its legal basis, Sebastián Mantilla-Blanco, in his research paper of the 
Interpretation of the WTO Agreement, has given four guidelines for 
consideration. Saying, first, such rule by its nature, must be relevant for 
the interpretation of any international regime. Second, the rule must be 
applicable in the relations between the parties. Third, the relevance of 
non-mandatory rules must be assessed on a case-by-case basis, bear-
ing in mind that their applicability to a specific relationship depends 
on the objectively-ascertained intention of the parties. And forth, the 
source of a rule will not affect its application in this context. As previ-
ously ruled by the Panel in EC-Biotech that the term “rules of interna-
tional law” as used in VCLT Article 31.3(c) is broad enough to cover all 
general sources of international law49, then the second criteria seems 
holding the key in order to decide whether the FCTC can be classified 
as a relevant rule of international law beAccording to this issue, the 
Panel in EC-Approval and Marketing of Biotech Products50 had previ-
ously suggested that “the parties” shall mean all the WTO Members, 
such that only a treaty to which all WTO Members are party could be 
counted as a rule of international law pursuant to VCLT Article 31.3(c). 
As the trend shows in i) the US-Clove Cigarettes that somehow demon-
strates the correlation of FCTC and the WTO covered agreement, and 
ii) the decision made by the Panel in EC-Approval and Marketing of 
Biotech Products that somehow supports the use of FCTC for purpose 
of interpretation51, together with iii) the recent opinions made by Pas-
cal Lamy, the Director-General of WTO and Dr. Margaret Chan, the 
Director-General of WHO, confirming that WTO rules and the imple-
mentation of the FCTC are actually in line and in fact compatible52, the 
2006) [hereinafter EC-Approval and Marketing of Biotech Products]. “we recognize that 
a proper interpretation of the term “the parties” must also take account of the fact that 
Article 31(3)(c) of the Vienna Convention is considered an expression of the “principle of 
systematic integration”… in a multilateral context such as the WTO, when recourse is had 
to a non-WTO rule for the purposes of interpreting provisions of the WTO agreements, a 
delicate balance must be stuck…”. 
49  See Blanco, supra note 46, at 111.
50  See EC- Approval and Marketing of Biotech Products Panel Report, supra note 47 . 
51  Id., 7.94. “the mere fact that one or more disputing parties are not parties to a convention 
does not necessarily mean that a convention cannot shed light on the meaning and scope 
of a treaty term to be interpreted”.
52  WHO Framework Convention on Tobacco Control, WTO Rules and the Implementa-
tion of the WHO FCTC are not incompatible (2011), available at http://www.who.int/fctc/
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multilateral instruments such as the FCTC can (or should) at least be 
relevant to determine “ordinary meaning” of particular terms pursuant 
to the VCLT Article 31.1 as of the same logic of applying GATT’s ne-
cessity test to the term “necessary” appeared elsewhere in other treaties. 
This is regardless of any practice followed by the parties (if any) that 
can possibly be amounted to “subsequent practice” by means of VCLT 
Article 31.3(b). 
IV. LEGAL ANALYSIS ON LEGITIMACY OF HEALTH WARN-
ING LABEL AND PLAIN PACKAGING REGULATIONS UN-
DER TRIPS
A. HEALTH WARNING LABEL REQUIREMENT AND PLAIN-
PACKAGING REGULATION ON TOBACCO
Under the Framework Convention on Tobacco Control, warning 
label regulation is understood as a health warning requirement for 
package of tobacco product which describes harmful effects of tobacco 
use and regulated by competent national authority. Within different 
jurisdictions and under different legal systems, the requirement of the 
health warning label may be regulated in a different manner and level, 
basing on national health policy specifically set by Member states that in 
any case would deem legitimate as long as the standard in FCTC is met53 . 
Despite of the proportion of the warning label that the regulation may 
require, there is a common form of pictorial warning and/or messages 
imposed by WTO Members that can possibly amount to a restriction of 
trademark use. In EU, according to the Directive adopted in 2001, the 
label requirement mandates that the two most visible surface of every 
cigarette package shall display a warning label at least 30 percent of 
the most visible exterior. The proportion may be increased up to 35 
percent if Members have official languages up to three54 . Similar to the 
FSPTCA of the US that requires top half of the front and rear panels of 
wto_fctc/en/index.html (last visited Jun. 18, 2012). 
53  FCTC art. 1(b)(i) provides: “(b) each unit packet and package of tobacco products and 
any outside packaging and labelling of such products also carry health warnings describ-
ing the harmful effects of tobacco use, and may include other appropriate messages. These 
warnings and messages: (i) shall be approved by the competent national authority…”
54  See Hackman, supra note 10, at 811-813.
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cigarette packs to contain one of the nine warnings, showing the risks 
of smoking and a warning message, up to 70 percent of the warning 
area55. While in Thailand, the Tobacco Products Control Act B.E. 
2535 requires pictorial warning label at the proportion of 55 percent56 . 
Notwithstanding the percentage that each country’s law requires, the 
regulations commonly limit the appearance of tobacco trademark that 
may communicate to public and prevent owners from their use. Even 
at this time when the plain packaging regulation was first introduced 
in Australia, offering public a concrete form of a tighten measure that 
steps beyond a simple health warning label to a smaller and stricter 
scope by forcing the use of trademark (either via registration or use) 
to be restricted in a single form of a plain, standard font, size, color 
and identical design of word without device57, these bring a significant 
question on legitimacy and compatibility of the regulations with the 
international intellectual property obligations such as TRIPS.
B. COMPATIBILITY OF THE TOBACCO MEASURES WITH TRIPS
Among various arguments alleged by tobacco companies, criticisms 
brought against tobacco measures, in the context of trademark, are 
mostly and commonly on the claims of i) infringement and devaluation 
of protected trademarks58, ii) denigration of trademark goodwill and 
value through the use of pictorial warnings59, iii) expropriation of 
property and private right by limiting their right to use60, and iv) its 
incompatibility with the provisions of TRIPS, namely Article 15.4, 16, 
55  Id., at 817-818.
56  See supra note 8, sec.12; See also Thailand’s Ministry of Public Health Notice of 
Rules, Procedures, and Conditions for the Display and Content of Cigarette Labels (2009), 
available at http://www.tobaccocontrollaws.org/files/live/Thailand/Thailand%20-%20
Cigarette%20Label%20Regs%202009.pdf (last visited Aug. 25, 2013).
57  See Vadi, supra note 3, at 96-97. “Plain packaging is a packaging regime that requires 
the removal of colors, designs, and logos from cigarette packs while allowing the brand 
name to be displayed in a standard font. Plain packaging is to reduce the incidence of 
smoking by making cigarette packets less appealing. The Bill will require all cigarettes to 
be sold in unattractive olive-green packs”; See also McGrady, supra note 29 .
58  See Hackman, supra note 10, at 818-819.
59  See Vadi, supra note 3, at 106-107.
60  Sam Foster Halabi, International Trademark Protection and Global Public Health: A 
Just-Compensation Regime for Expropriations and Regulatory Takings, 61 Cath. U. L. 
Rev. 325 (2012), at 345.
572 Volume 11 Number 4 July 2014
Jurnal Hukum Internasional
17, 20, and unjustification pursuant to Article 8.1. As the terms provided 
in TRIPS are flexible and reserved for members’ implementation61, 
TRIPS can thus be understood when the VCLT is brought to interpret 
together with precedents ruled by Panel and AB that possibly guide 
to a feasible solution may adopt by WTO62 . To the extent that some 
proponents view tobacco measures as a fair use exempted by Article 
17, while opposers yet reject such argument, the following analysis 
will therefore extract individual elements of the Articles, including 
Article 15.4 and Article 20, and discuss all in details. With regards to 
the challenge on the fair-use exception, Articles 16 and 17 of the TRIPS 
provide:
TRIPS: Article 16 and 17
Art. 16.1 (Right Conferred) Art . 17
The owner of a registered trademark 
shall have the exclusive right to prevent 
all third parties not having the owner’s 
consent from using in the course of trade 
identical or similar signs for goods or 
services which are identical or similar to 
those in respect of which the trademark is 
registered where such use would result in 
a likelihood of confusion…
Members may provide limited exceptions 
to the rights conferred by a trademark, such 
as fair use of descriptive terms, provided 
that such exceptions take account of the 
legitimate interests of the owner of the 
trademark and of third parties
To view the warning label and the plain package regulations as fair-
use, the conditions in Article 17 literally communicate the rule provid-
ing that the exception must be limited and be exception to the right 
conferred. Without a right to protect, there is likely no exception would 
be required. At the heart of the debate, the key would then underline 
the ordinary meaning of the term “right conferred” in Article 16 and 
61  TRIPS art.1.1 provides: “Members shall give effect to the provisions of this Agreement. 
Members may, but shall not be obliged to, implement in their law more extensive protec-
tion than is required by this Agreement, provided that such protection does not contra-
vene the provisions of this Agreement. Members shall be free to determine the appropriate 
method of implementing the provisions of this Agreement within their own legal system 
and practice”.
62  See supra note 22 . 
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capture their correlation to form a holistic understanding. Simply, the 
provision states that the owner of a registered trademark shall have the 
exclusive right to prevent a third party to use identical/similar mark on 
similar products that would likely cause confusion to consumers. It is a 
matter of fact that the right granted is the right of exclusivity which its 
nature can exemplify the negativity or negative right to exclude the use 
of trademark by someone else. As positive right can easily understand 
as the right to use, none of the provision in the article entitles tobacco 
companies to protest or claim when their right is restricted (or limited) 
for such a vital purpose like public health. Furthermore, as it was earlier 
mentioned in the EC-Protection of Trademarks and Geographical Indi-
cations for Agricultural Products and Foodstuffs 63, the Panel noted that;
“The limited exceptions apply to the right conferred by a trade-
mark… Article 17 permits exceptions, to rights to exclude legitimate 
competition, rather, they confer, inter alia, the right to prevent uses 
that would result in a likelihood of confusion”
It can hence be argued that the claim earlier made by tobacco com-
panies is in no way compliance with the provisions in TRIPS. Whereby 
TRIPS provides flexibility in implementation to Member states via Ar-
ticle 1.1, positive right (i.e. right to use) is de facto provided at a do-
mestic level during the process of national implementation64 rather than 
in the international level. It then sounds unreasonable to claim that the 
restriction of tobacco measures to use trademark would amount to a 
violation of TRIPS. Added in support by the TRIPS’s preparatory work 
in the light of VCLT Article 3265, the history also confirms our conclu-
63  Panel Report, EC-Protection of Trademarks and Geographical Indications for Agricul-
tural Products and Foodstuffs, 7.651, WT/DS290/R (Mar. 15, 2005)
64  For instance, rights i) to authorize other persons to use trademark [Section 20(1)(b)], ii) 
to bring an action for infringement of trademark [Section 26(1)(b)], iii) to display trade-
mark on goods in respect of which the trademark is registered or on their packages or 
containers [Section 26(1)(c)], v) to permit any person to apply trademark to goods [Sec-
tion 26(1)(f)], v) to assign a registered trademark [Section 106(1)] and etc., as literally 
explain in the Australian Trademark Act 1995, though there is yet a dissent on the nature 
of trademark right appeared in the high court of Australia (See JT International SA v. 
Commonwealth of Australia and British American Tobacco Australasia Limited v. The 
Commonwealth). Other countries’ trademark laws, such as Thailand, are also promulgated 
in the same manner .
65  VCLT art. 32 provides: “Supplementary Means of Interpretation: Recourse may be had 
to supplementary means of interpretation, including the preparatory work of the treaty and 
574 Volume 11 Number 4 July 2014
Jurnal Hukum Internasional
sion, provided that the content of Article 16.1 is the result of the second 
phase of discussion, triggered by the EC proposal of the draft in 1990, 
which its emphasis was initially on the negative right, the claim of the 
tobacco companies is hence unpersuasive and also unreasonable. 
As interest in using trademarks is deeply connected to its capability 
of being distinguish goods of undertakings in the course of trade from 
of others at the gist of the trademark law, acknowledged by the Panel’s 
decision in EC-Protection of Trademarks and Geographical Indications 
for Agricultural Products and Foodstuffs 66, trademarks can yet be ex-
pected to perform its function though tobacco measures are in force67. 
This is because the word-mark68 is yet allowed to indicate and com-
municate to consumers of its origin in a specific form, now prescribed 
by specific law, namely the warning label and the plain package. TRIPS 
does not oblige WTO Members to provide trademark holders with a 
right to use their marks69 .
TRIPS: Article 2
the circumstances of its conclusion, in order to confirm the meaning resulting from the ap-
plication of Article 31, or to determine the meaning when the interpretation according to 
Article 31: (a) Leaves the meaning ambiguous or obscure; or (b) Leads to a result which is 
manifestly absurd or unreasonable”.
66  See supra note 62. “The TRIPS Agreement itself sets out a statement of what all WTO 
Members consider adequate standards and principles concerning trademark protection. Al-
though it sets out standards for legal rights, it also provides guidance as to WTO Members’ 
shared understandings of the policies and norms relevant to trademarks and, hence, what 
might be the legitimate interests of trademark owners. The function of trademarks can be 
understood by references to Article 15.1 as distinguishing goods and services of undertak-
ings in the course of trade. Every trademark owner has a legitimate interest in preserving 
the distinctiveness, or capacity to distinguish, of its trademark so that it can perform that 
function. This includes its interest in using its own trademark in connection with the rel-
evant goods and services of its own and authorized undertakings. Taking account of that 
legitimate interest will also take account of the trademark owner’s interest in the economic 
value of its mark arising from the reputation that it enjoys and the quality that it denotes”.
67  See general Halabi, supra note 59 .
68  There are generally two types of trademarks, namely i) word marks (i.e. the characters 
comprising the name of a brand) and ii) non-word marks (i.e. device, figurative or stylized 
marks) such as logos and combined marks containing stylized letters, shape marks and 
color marks. Some may refer to this non-word mark as a device mark. Please take Marl-
boro, a famous mark of tobacco products, as an example.
69  See EC-Protection of Trademarks and Geographical Indications for Agricultural Prod-
ucts and Foodstuffs Panel Report, supra note 62, para.7.610-7.611; See also McGrady, 
supra note 29 . 
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Art . 20 Interpretative Tool
VCLT Art.31.1
The use of trademark in the 
course of trade shall not be 
unjustifiably encumbered by 
special requirements, such as 
use with another trademark, 
use in a special form or use 
in a manner detrimental to 
its capacity to distinguish 
the goods or services of one 
undertaking from those of 
other undertakings…
Ordinary Meaning:
1. There is a special requirement(s)
2. Such requirement is related to the course 
of trade
3. Such requirement must be unjustifiably 
(unjustified)
4. There is encumbrance arisen from such 
requirement
5. Encumbrance is to the use of mark
Notwithstanding the exclusive right provided by TRIPS, the Agree-
ment further recognizes trademark as a private right in paragraph four 
of its Preamble70. It is an affirmation of capitalistic principle that is 
translated into Article 2071 and aim to outlaw special requirement mak-
ing use of trademark difficult in the course of trade and to save owners 
from unjustified encumbrances. As touched many times by commenta-
tors in their research, Article 20 likely provides a strongest opposition 
for tobacco companies to be against tobacco measures as its character 
appears to be within scope of the Article 20. Found in the article, the 
law requires a numbers of proof to show that i) there is a special re-
quirement imposed, ii) the requirement imposed is related to the course 
of trade, iii) what imposed in the course of trade is unjustified, iv) such 
unjustified requirement causes encumbrance, and v) that encumbrance 
influences the use of mark. “Requirement”, per its wording, is referring 
to the act of demand, requisition, or requiring. While “encumbrance” 
70  See supra note 18.
71  Nuno Pires de Carvalho, The TRIPS Regime of Trademarks and Designs, 89 
(1993), at 45.
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would mean an obstruction that impedes or a burden72, the entire provi-
sion thus gives us an understanding that Article 20 shall denote a “spe-
cial” demand or requirement, but not voluntariness73, in a sense that 
a trademark use in the course of trade will be prohibited or restricted 
and finally causes obstruction to trademark owners. To the extent that 
the warning label and plain packaging regulations restrict the use of 
trademarks in various formats prescribed by laws, it seems reasonable 
to conclude that Article 20 would likely apply to both the measures that 
prevent trademark from performing their functions. 
Now turning us to the consideration of “unjustification” last men-
tioned in the article, “justified”, according to Wordnet dictionary, means 
to show or prove to be just, right or reasonable. So, to be seen as “just”, 
there must be a goal to be pursued. At least those that are prohibited 
under GATT should not be considered legitimate or “just”74 in pursuit 
of the law. The AB, in Brazil-Measures Affecting Imports of Retreaded 
Tyres75, has mentioned that discrimination would be arbitrary or unjus-
tifiably when i) the reasons given for discrimination bear no rational 
connection to the objective falling within the purview of a paragraph 
of Article XX, or ii) would go against that objective. Thus, in order to 
conclude whether the tobacco measures are unjustifiable, there must 
first be i) a public health policy and objective of invoking state that fall 
within GATT Article XX(b)76 and ii) also a proof that the measures can 
achieve such goal. 
72  See generally Wordnet dictionary
73  See Panel Report, Indonesia-Certain Measures Affecting the Automobile Industry, 
14.278, WT/DS54/R (Jul. 2, 1998).
74  Nuno Pires de Carvalho, The TRIPS Regime of Trademarks and Designs, 89 (1993), 
at 329 .
75  Appellate Body Report, Brazil-Measures Affecting Imports of Retreaded Tyres, 227, 
WT/DS332/AB/R (Dec. 3, 2007).
76  General Agreement on Tariffs and Trade 1994, Apr. 15, 1994, Marrakesh Agreement 
Establishing the World Trade Organization, Annex 1A, THE LEGAL TEXTS: THE RE-
SULTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS 
17 (1999), 1867 U.N.T.S. 187, 33 I.L.M. 1153 (1994) [hereinafter GATT 1994] art. XX(b) 
provides: “Subject to the requirement that such measures are not applied in a manner 
which would constitute a means of arbitrary or unjustifiable discrimination between coun-
tries where the same conditions prevail, or a disguised restriction on international trade, 
nothing in this Agreement shall be construed to prevent the adoption or enforcement by 
any contracting party of measures: …(b) necessary to protect human, animal or plant life 
or health…”.
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For long that justification has been treated as close to the necessity 
test in many WTO case law77, this may imply a requirement of applying 
the test in the proof of justification according to TRIPS Article 20, in 
the light of the GATT, due to the WTO dispute procedure78 . In the con-
text of Australia, for example, the objectives of adopting the warning 
label requirement is to i) increase consumer knowledge of health effects 
relating to smoking and ii) to encourage the cessation of smoking and 
to discourage uptake or relapse, along with a number of requirements 
specified in the Trade Practice (Consumer Product Information Stan-
dards) (Tobacco) Regulations 2004. The measure is viewed, at least, 
not against its objectives and likely consistent. It is deemed justifiable 
according to the above interpretation with support from the case law. 
While the plain package, the objectives set out in Section 3 of the To-
bacco Plain Packaging Act 201179 is broad enough to possibly conclude 
that the measure undertaken is also consistent (emphasis added). Likely, 
the measure requirements related to public policy objective are usually 
recognized and accepted to be justifiable (emphasis added) 80 . Though 
there is a number of scholars and researchers in support this notion81, 
this paper argues that it is not always the case. Based on the VCLT Ar-
77  See Daniel Gervais, Analysis of the Compatibility of certain Tobacco Product Packag-
ing Rules with the TRIPS Agreement and the Paris Convention (2010), at 29, available at 
http://www.smoke-free.ca/trade-and-tobacco/Resources/Gervais.pdf (last visited Aug. 26, 
2013).
78  Id., at 28.
79  See supra note 27, sec. 3 provides: “Objects of this Act, (1) The objects of this Act 
are:(a) to improve public health by:(i) discouraging people from taking up smoking, or 
using tobacco products; and (ii) encouraging people to give up smoking, and to stop using 
tobacco products; and (iii) discouraging people who have given up smoking, or who have 
stopped using tobacco products, from relapsing; and (iv) reducing people’s exposure to 
smoke from tobacco products; and (b) to give effect to certain obligations that Australia 
has as a party to the Convention on Tobacco Control.
(2) It is the intention of the Parliament to contribute to achieving the objects in subsection 
(1) by regulating the retail packaging and appearance of tobacco products in order to:(a) 
reduce the appeal of tobacco products to consumers; and (b) increase the effectiveness of 
health warnings on the retail packaging of tobacco products; and (c) reduce the ability of 
the retail packaging of tobacco products to mislead consumers about the harmful effects of 
smoking or using tobacco products”.
80  See Carvalho, supra note 73, at 330; See also Alberto Alemanno and Enrico Bonadio, 
Do you Mind My Smoking? Plain Packaging of Cigarettes under the TRIPS Agreement, 10 
J. Marshall Rev. Intell. Prop. L. 450 (2011), at 464-465.
81  Id. 
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ticle 31.1, to make our interpretation entirely and holistically coherent, 
it is worth noting that interpretation should also be consistent with the 
principle provision in TRIPS Article 8. The provision reads :
Art. 8.1 (Principles)
Members may, in formulating or amending their laws and regulations, adopted 
measures necessary to protect public health and nutrition, and to promote the public 
interest in sectors of vital importance to their socio-economic and technological 
development, provided that such measures are consistent with the provisions of 
this Agreement
Rather than overriding Members’ obligations82, Article 8 likely 
works to interpret and mirror the main purpose of balancing the right 
to promote public interest in sectors of vital importance to their socio-
economic and technological development, provided that such measures 
are consistent with the provisions in TRIPS. With regards to this issue, 
Member states can adopt measures to protect public health and nutrition 
as long as it is “necessary” 83 . As the term used in Article 8.1 is different 
to the term used in the Article 20, by viewing the term on as-is basis, it 
can be reasonably expected that the standard of proving or threshold of 
justifiability should therefore be lower than the threshold of the neces-
sity test84 . Similar to the AB’s decision in Brazil-Measures Affecting 
Imports of Retreaded Tyres, the invoking Member would then need to 
demonstrate a genuine relationship of ends and means between the ob-
jective pursued and the measures at issue, such that the measure brings 
about a material contribution to achieve its objective85 . A Member may 
also demonstrate this through evidence of a qualitative or quantitative 
nature, given that no set requirements on the type of evidence that a 
Member must have to support implementation of a measure and a mem-
ber needs not prove that the measure will be effective in achieving its 
82  See Gervais, supra note 76, at 17.
83  See supra note 75 .
84  See McGrady, supra note 29, at 4. 
85  See supra note 74, para. 145.
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objective because it can only be evaluated with the benefit of time86. 
To prove “necessary”, Panel and AB have previously ruled in the 
two important cases which set standard in their precedents. Here, US-
Standard for Reformulated and Conventional Gasoline in 1996 (Panel) 
and US-Import Prohibition of Certain Shrimp and Shrimp Products in 
1998 (AB), both have sum up the three major elements to qualify “neces-
sary”. That to be said, in order to be necessary, i) there must be a policy 
in respect of the measure designed to protect public health, ii) there is 
correlation between the measure and policy objective that is necessary 
to fulfill, and iii) such measure is the only way to accomplish the policy, 
given that no other less restrictive measure than the one intended. Thus, 
while there is no common statistical information confirms efficiency of 
tobacco measures, especially the plain-packaging, towards tobacco con-
sumption87, this paper found it difficult to conclude that the plain packag-
ing regulation, in particular, would then be justifiable unless the objective 
in public health is set at the maximum as to protect the entire nation from 
being in touch with tobacco. To the extent that this research argues that 
impacts resulted from the plain package on trademark use will likely be 
tremendous88, by comparing to the case EC-Measures Affecting Asbes-
tos and Asbestos-Containing Products89, it is still possible that the plain 
packaging regulation can yet amount to the term necessary and justifiable 
subject to Article 20 in the light of the TRIPS’s principle in Article 8. 
Supported by the Panel’s decision in European Communities I90 and the 
latter case of Thai Cigarette in 199091, the level of public policy objective 
is therefore left up to Members to decide. 
86  Id., para 151.
87  See Gervais, supra note 76, at 27.
88  See C. The Stricter, the Better? Impacts on Trademark System in Practice
89  Appellate Body Report, European Communities - Measures Affecting Asbestos and As-
bestos-Containing Products, WT/DS135/AB/R (Mar. 12, 2001) [hereinafter EC-Measures 
Affecting Asbestos and Asbestos-Containing Products]; Panel Report, European Com-
munities - Measures Affecting Asbestos and Asbestos-Containing Products, WT/DS135/R 
(Sep. 18, 2000).
90  See Carvalho, supra note 73, at 190. “…paragraph one of Article 8 reflects the fact that 
the TRIPS Agreement does not generally provide for the grant of positive rights to exploit 
for use certain subject matter, but rather provides for the grant of negative rights to prevent 
certain acts. This fundamental feature of IP protection inherently grants Members freedom 
to pursue legitimate public policy objectives…”.
91  See supra note 9 .
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V. THE STRICTER, THE BETTER? IMPACTS ON TRADE-
MARK SYSTEM IN PRACTICE
Though the balance can be maintained via interpretative tool such 
as ordinary meaning, object and purpose, and subsequent agreement, 
i.e. the Doha Declaration, that recently confirmed in the US-Clove Cig-
arettes, it does not change the fact that there are likely impacts result-
ed from the imposition of tobacco measures. At this point of problem 
where general research hardly touched on, as the use of trademark on 
tobacco in the context of plain package is now limited to only the plain 
text, while devices and figures are required to be taken down, the limita-
tion thus raises a number of questions to courts, government registrars 
and IP lawyers on how the measures are supposed to work in conjunc-
tion with current practice where the fact of “trademark use” (as opposed 
to non-use) is very much important.  
1. Trademark Use: Acquisition of Trademark Protection (Via Use)
Trademark use has long been acknowledged and recognized in 
trademark law of its vital function on distinctiveness that relates to con-
sumers’ capability of distinguishing source or origin of products. In the 
context of trademark acquisition, many civil law system and almost 
Anglo-American common law countries give trademark protection 
through the use of a mark if it is capable of distinguishing one’s source 
of product from others92 . To the extent that the use of trademark is now 
limited as the result of the plain packaging regulation, distinctiveness 
is expected to be hard for marks’ owners to establish, through the use 
of plain text without figures or devices, that would create brand image 
in minds of consumers. Especially for tobacco product which its ad-
vertising is prohibited in many countries’ laws, brand image will likely 
require a longer time and effort until a mark will become distinguish-
able. Possibly that a mark being limited by force of the health warning 
label will also face the same dilemma, the problem in this case will be 
very less severe comparing to the plain package as its word marks can 
nonetheless indicate and communicate to consumers its origin.  Though 
the plain packaging measure may be considered legitimate as explained 
in the previous chapter, the impact to the acquisition of trademark pro-
92  See Gervais, supra note 76, at 16.
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tection via use is yet another issue which is a big question to users and 
also legislators to dwell.  
2. Trademark Use: Registration of a New Mark and Trademark 
Infringement (Likelihood of Confusion)
Another issue related to trademark use is the analysis on the level of 
similarity appeared in most of the countries’ trademark registration. In 
case where a mark in application is consisted of both wording and de-
vice, analysis or consideration of a trademark registrar on similarity of 
the two marks will generally be on the mark entirely comparing to the 
previous ones registered (emphasis added). As the use of a registered 
trademark relating to tobacco will now be limited and different from 
what they formerly registered with IP office, the question will then be 
how a registrar and court will scrutinize the similarity. While there is 
much uncertainty under the current system, it is foreseeably that the 
solution may base on two different approaches. 
First, “as-is” basis, according to this approach, registrars may scru-
tinize similarity of the two marks basing on documents and samples of 
the marks provided without taking the fact of actual use into account. 
However, as the trademark use is undeniably related to the scope of 
protection and public’s likelihood of confusion, the actual use will then, 
to some extent, influence the scrutiny in registrars’ minds, causing them 
to possibly switch to the second approach where the consideration will 
base on the use of plain text in the case of plain package. According to 
TRIPS Article 15.4, this will likely pose a further question on legiti-
macy of using the registrars’ discretion, the provision reads; 
TRIPS: Article 15.4
Art. 15.4 (Protectable Subject Matter)
The nature of the goods or services to which a trademark is to be applied shall in 
no case form an obstacle to registration of the trademark
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This paper argues that registrars will likely encounter difficulty of 
implementing the second approach, provided that the discretion on 
comparing the similarity will likely be in violation of Article 15.4 of 
the TRIPS. This is because the focus of comparison is now on the na-
ture of tobacco product. Very much likely that registrars will choose the 
“as-is” basis approach, fraudulent applicant may take advantage from 
this weakness by creating a mark with fancy device and stylized word-
ing with different spelling and sound, i.e. Marlboro vs. Morlbare, as to 
deceive public in terms of origin or source of product that will generally 
amount to trademark infringement. As such mark, in comparison to the 
registered mark, would be deemed different on its sound and device but 
similar in spelling, the all-combined deception, which may entirely ap-
pear to be sufficiently distinctive, may cause likelihood of confusion to 
public once it is accepted for registration and used on tobacco product 
by force of the plain packaging regulation. Will this later case amount 
to infringement of the Marlboro trademark as it would likely cause con-
fusion to consumers and mislead public?
Another example that would cause problem on trademark is a gener-
ic mark whereby its protection and distinctiveness can acquire through 
a combination of stylized wording and devices. When these are all com-
bined together, registrar will usually require an applicant to disclaim on 
the generic word partially form and contribute as the whole registered 
trademark. As its right of protection will be limited and scoped on any 
device and/or components forming an entire registered mark, once it is 
registered and applied on a plain package of tobacco, it is hard to imag-
ine how the registrar and court will deal with the situation in practice 
when merely an generic word is now appeared on tobacco product by 
force of the plain packaging law. Though the provisions are consid-
ered legitimate and compatible with the TRIPS, the problem is hard 
to imagine and the refusal of a registrar for trademark registration will 
also likely amount to the violation of TRIPS Article 15.4. Similar to our 
previous analysis, the problem is yet remained to be seen and suggests 
Members to beware if they intend to apply the regulation in the future93 .
93  Currently, United Kingdom and New Zealand are considering of adopting tobacco plain 
packaging regulation to control tobacco product distributed in the countries; See Voon, 
supra note 5, at 118.
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3. Trademark Use: Cancellation of Trademark (Non-Use)
In many countries’ national trademark laws, non-use of a registered 
trademark may cause cancellation or revocation as trademark is recog-
nized by Paris Convention as industrial property protected for business 
purpose. Because of some components of a registered mark that must 
be taken down and leave the use to merely on a plain word, question 
regarding non-use of components is then arisen if this amounts to a 
cancellation. Regarding this particular issue, Australian Tobacco Plain 
Packaging Act, explicitly regulates that non-use of a trademark for the 
purpose of complying with the Act does not provide a basis for revok-
ing or refusing to register 94. To the extent that this exception clause 
applies to both i) revocation of trademark and ii) refusal to register a 
trademark based on the reason of non-use , the correlation of this Act 
to the Australian trademark law seems to provide a compromising so-
lution to the problem on cancellation but unlikely to the problem on 
registration of trademark. Only in the situation where trademark use 
is a pre-condition to apply or file for trademark registration that this 
clause would benefit, without devices or other compositions, such ex-
ception would not change the fact that distinctiveness and brand image 
are yet difficult to be created to acquire protection via use in minds 
of consumers. Similar to the second problem on registration of a new 
mark explained above, this exception clause is seen having limitation 
on its scope in implementation. Likely, the health warning label owns 
a lesser number of problems in comparison with the plain package im-
posed by Australia. So, will the stricter regulation always be better?  By 
taking these impacts on trademark practice into account, whereas the 
effectiveness of the regulation is yet suspicious, these may second the 
implementing country to re-estimate the measure before adopting radi-
94  See supra note 27, sec. 28(3) provides: “To avoid doubt, for the purposes of sections 
38 and 84A of the
Trade Marks Act 1995, and regulations 17A.27 and 17A.42A of the Trade Marks Regula-
tions 1995: (a) the operation of this Act; or (b) the circumstance that a person is prevented, 
by or under this Act, from using a trade mark on or in relation to the retail packaging of 
tobacco products, or on tobacco products; are not circumstances that make it reasonable 
or appropriate: (c) not to register the trade mark; or (d) to revoke the acceptance of an 
application for registration of the trade mark; or (e) to register the trade mark subject to 
conditions or limitations; or (f) to revoke the registration of the trade mark”.
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cal approach on tobacco control such as the plan package. This is unless 
the national trademark system is entirely reformed and adjusted for its 
full implementation.
4. Trademark Use: The Use of Misleading Word
As the result of tobacco measures, there is also a claim that restric-
tion of the use of trademark will amount to limitation on the use of 
components incorporated into a cigarette name, such as “mild”, “light”, 
and “ultra-light” descriptors commonly seen in market, that are legiti-
mate and available95. To our notice that tobacco manufacturers and 
their affiliated advertisers have strategies to frame the information on 
its package, including the shape and size of the package by using such 
descriptors96, to create credence qualities in products through design 
suggestion and implication to make consumers believed that smoking a 
“mild” cigarette, for example, constitutes a positive health measure97, 
it is also questionable if such restriction will constitute a trademark in-
fringement98. 
Looking the problem from international law perspective, through 
the use of TRIPS Article 1.1 and Article 2.199 and Article 6quinquies of 
the Paris Convention100, the misleading representations can actually be 
95  See Vadi, supra note 3, at 105-106. “Tobacco company usually claims that the terms 
“light”, “mild”, and “low” were incorporated into cigarette names and communicated dif-
ferences of taste to consumers and such banning would not only destroy valuable trade-
marks and the goods that they represent but would also tantamount to indirect expropria-
tion”.
96  See Halabi, supra note 59, at 350-351.
97  Id., at 353-355.
98  See Vadi, supra note 3, at 123-124.
99  TRIPS art.2 provides: “In respect of Parts II, III and IV of this Agreement, Members 
shall comply with Articles 1 through 12, and Article 19, of the Paris Convention (1967)”.
100  Paris Convention for the Protection of Industrial Property of 1883, 25 Stat. 1372, T.S. 
No. 379, 10 Martens Nouveau Recueil 2d 133, revised Dec. 14, 1900, 32 Stat. 1936, T.S. 
No. 411, 30 Martens Nouveau Recueil 2d 465, revised June 2, 1911, 38 Stat. 1645, T.S. 
No. 579, 8 Martens Nouveau Recueil 3d 760, revised Nov. 6, 1925, 47 Stat. 1789, T.S. 
No. 834, 74 L.N.T.S. 289, revised June 2, 1934, 53 Stat. 1748, T.S. No. 941, 192 L.N.T.S. 
17, revised Oct. 31, 1958, 13 U.S.T. 1, T.I.A.S. No. 4931, 828 U.N.T.S. 107, revised July 
14, 1967, 21 U.S.T. 1583, T.I.A.S. No. 6923, 828 U.N.T.S. 305 [hereinafter Paris Con-
vention] art. 6quinquies.B provides: “Trademarks covered by this Article may be neither 
denied registration nor invalidated except in the following cases: (i) when they are of such 
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rejected by law as it is likely contrary to public order. Particularly in this 
issue, there are scholars, through their research, proposed “ex-ante” and 
“ex-post” approaches to prevent such unpleasant dilemma 101. To our 
notice that only the ex-ante approach that is relevant to our problem of 
the misleading representation102, this paper argues that legislation can 
thus be used to pose additional requirements of trademark eligibility to 
prevent the problem as long as it does not conflict or violate provisions 
in TRIPS, namely Articles 15.4 and 20 and by means of Paris Conven-
tion Article 6quinquies. By taking Australian Trademark Law103 and 
the US’s104, as an example, restriction on the use of misleading words 
or waiver of the claim of protection can actually be done by excluding 
them from incorporating in a trademark. This thus rebuts the argument 
of tobacco companies on the ground of legitimacy. Supported by medi-
cal evidence which shows that smokers would likely adopt a “light” 
version of a cigarette as a health measure, often as an alternative to quit 
smoking105, the current mechanism can therefore provide a perfect so-
lution to the current problem resulted from tobacco measures. 
VI. CONCLUSION
The battle and claims of tobacco companies against health warn-
ing label and plain packaging regulations adopted in many countries 
have highlighted some significant issues concerning TRIPS that we 
have overlooked for many years.  Many problems argued by tobacco 
a nature as to infringe rights acquired by third parties in the country where protection is 
claimed; (ii) when they are devoid of any distinctive character, …or have become custom-
ary in the current language or in the bona fide and established practices of the trade of the 
country where protection is claimed; (iii) when they are contrary to morality or public 
order and, in particular, of such a nature as to deceive the public…”.
101  See general Halabi, supra note 59 . 
102  Id., at 356-357. The ex-post approach was recently proposed by Prof. Sam Foster 
Halabi, College of Law, University of Tulsa.
103  Australia Trademarks Act 1995, sec. 43 provides: “An application for the registration 
of a trademark in respect of particular goods or services must be rejected if, because of 
some connotation that the trademark or a sign contained in the trademark has, the use of 
the trademark in relation to those goods or services would be likely to deceive or cause 
confusion”. 
104  See Halabi, supra note 59, at 369-370.
105  Id., at 370-371.
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companies are unlikely found in the contents of the TRIPS as priority 
of WTO Members in their early negotiation was on the bargain in patent 
provisions and the drafters’ willingness to leave it opened for purpose 
of flexibility.
To provide analyzing steps to rely on, the Vienna Convention on the 
Law of Treaties or VCLT is necessary to be used to project the gist of 
the TRIPS and reveal the results of the Members’ negotiations. Among 
the eighty five provisions, Articles 31 and 32 are very likely relevant 
to our understanding of the provisions in TRIPS by relying on its or-
dinary meaning in the light of its object and purpose. Together with 
previous decisions ruled by the DSB, the analysis revealed that among 
other claims, problems are mostly clustered on Articles 15.4, 16, 17 and 
20, which is deeply connected to interpretation of justification and ne-
cessity under TRIPS Article 8.1. While the tobacco measures are seen 
falling under the scope of Article 20 provision, both regulations are 
likely found legitimate, justified, and compatible with TRIPS principle 
ruled in Article 8.1 as well as the Doha Declaration and the FCTC106 
with support from the DSB’s precedents and TRIPS’s  history found in 
its preparatory works. Moreover, as the provision of TRIPS Article 16 
is related to negative right, constituted as the right conferred of trade-
mark holders, and while the tobacco measures under consideration are 
not an exception to the right conferred specified thereof, the measures 
are therefore considered not in violation of the TRIPS in both Article 
16 and 17, as well as Article 15.4 that is regulated to merely prohibit 
discrimination on goods basing on nature that will form obstacles to 
trademark registration.
Trademark, unlike copyright and patent, is not intendedly protected 
to reward trademark creation but rather, it tires to the benefits mutually 
shared by manufacturers and also consumers. In review of the gist, i) 
the enhancement of fair competition, as to distinguish one’s source or 
origin of product (emphasis added) from competitors, and ii) reduction 
of consumers’ confusion and information cost are what the law mostly 
and profoundly emphasizes on107. Because the trademark law is origi-
106  See Section IV: Legal Analysis on Legitimacy of Health Warning Label and Plain Pack-
aging Regulations under TRIPS, B. Compatibility of the Tobacco Measures with TRIPS.
107  See Halabi, supra note 59, at 365-366.
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nally created to prevent consumers’ confusion and to provide fair com-
petition in market, as the result of the tobacco measures, trademarks’ 
capability of distinguishing origin or source of product is yet observed 
to remain though it is transformed into a form of a plain package or 
restricted in its size because of the health warning label requirement. 
Unless opposers can provide evidence showing that consumers will 
likely switch their consumption to a competing or like product in the 
same market, the measures would likely be considered legitimate and 
compatible to TRIPS where trademark distinctiveness is yet existed and 
subject to protection by virtue of the trademark law108.
Notwithstanding the tobacco measures’ legitimacy and compatibil-
ity to TRIPS, this paper argues that there shall also be some impacts 
resulted from the restriction of trademark use that would likely affect 
trademark system in practice. Based on the fact that trademark acqui-
sition, either via registration or use, trademark infringement and also 
trademark revocation, are all relying on the actual use of a trademark, 
discretion and standard of the courts and registrars in their consider-
ation of trademark acquisition, revocation, and infringement will also 
likely be changed in response to the development of tobacco control 
measure.
Rather to call for Members’ attention on the impacts, it is not the ob-
jective of this paper to oppose any radical implementation of any pub-
lic health measure or to be against the regulations which aim to bring 
healthier population and stronger development in Member countries. 
To fully implement public health policy in the WTO Member states 
without violating both international and national trademark laws, Mem-
bers are urged and encouraged to harmonize the systems with holistic 
approach, aiming to facilitate domestic health and the flow in trade si-
multaneously, in order to form a strong and balanced system to benefit 
right holders and also users. As previously observed through the use of 
Section 28 in Australian Tobacco Plain Packaging Act, though the pro-
vision is reserved to be further interpreted, the law is considered to be 
a good beginning of founding a harmonized system of trade and IP that 
other Member states can take into account. Among different approaches 
of tobacco measures such as the plain package and the public health 
108  See Vadi, supra note 3, at 122-124.
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warning label, countries may choose either a stricter or more flexible 
measure to implement. This is together with the number of unavoidable 
impacts that the Members shall always bear in mind. 
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